-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E9f2Cke9Via3lyBf/cjZMRW0iRuTGgfdke6IhogI9bW4rUYhbWIRipJRHBvJlUp+ MhlPKYDOtAA/JOwjRCRApQ== 0001140361-11-009497.txt : 20110215 0001140361-11-009497.hdr.sgml : 20110215 20110214184334 ACCESSION NUMBER: 0001140361-11-009497 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101231 FILED AS OF DATE: 20110215 DATE AS OF CHANGE: 20110214 EFFECTIVENESS DATE: 20110215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ayer Capital Management, LP CENTRAL INDEX KEY: 0001471149 IRS NUMBER: 262134101 STATE OF INCORPORATION: DE FISCAL YEAR END: 1209 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-13640 FILM NUMBER: 11609434 BUSINESS ADDRESS: STREET 1: 230 CALIFORNIA, SUITE 600 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 4158744800 MAIL ADDRESS: STREET 1: 230 CALIFORNIA, SUITE 600 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 form13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: 12/31/2010 Check here if Amendment []; Amendment Number: ------- This Amendment (Check only one.): [] is a restatement. [] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Ayer Capital Management, LP Address: 230 California Street, Suite 600 San Francisco, CA 94111 Form 13F File Number: The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Persons Signing this Report on Behalf of Reporting Manager: Name: Tom Glaser Title: CFO Phone: 415-874-4803 Signature, Place, and Date of Signing: /s/ Tom Glaser San Francisco, CA 2/14/2011 - --------------------------------- --------------------------------- ---------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 26 Form 13F Information Table Value Total: $ 98,920 -------------- (In Thousands) List of Other Included Managers: Provide a numbered list of the name(s) and 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE
FORM 13F INFORMATION TABLE COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 - -------------------------- -------------- --------- -------- ------------------ ---------- -------- --------------------- VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - -------------------------- -------------- --------- -------- --------- --- ---- ---------- -------- ---- ------ --------- AMERISOURCEBERGEN CORP COM 03073E105 1,915 56,124 SH SOLE 0 0 56,124 ALIMERA SCIENCES INC COM 016259103 2,993 288,313 SH SOLE 0 0 288,313 ARTHROCARE CORP COM 043136100 9,004 289,891 SH SOLE 0 0 289,891 ARYX THERAPEUTICS INC COM 043387109 73 270,595 SH SOLE 0 0 270,595 BIOSPECIFICS TECHNOLOGIES COM 090931106 7,646 298,687 SH SOLE 0 0 298,687 CERUS CORP COM 157085101 2,268 922,128 SH SOLE 0 0 922,128 CIGNA CORP COM 125509109 2,942 80,261 SH SOLE 0 0 80,261 CURIS INC COM 231269101 1,288 650,398 SH SOLE 0 0 650,398 DENDREON CORP COM 24823Q107 5,645 161,665 SH SOLE 0 0 161,665 DUSA PHARMACEUTICALS INC COM 266898105 1,260 514,242 SH SOLE 0 0 514,242 EXPRESS SCRIPTS INC COM 302182100 6,677 123,537 SH SOLE 0 0 123,537 INTERMUNE INC COM 45884X103 4,865 133,656 SH SOLE 0 0 133,656 MCKESSON CORP COM 58155Q103 8,709 123,739 SH SOLE 0 0 123,739 MEDCO HEALTH SOLUTIONS INC COM 58405U102 7,445 121,515 SH SOLE 0 0 121,515 NPS PHARMACEUTICALS INC COM 62936P103 2,090 264,589 SH SOLE 0 0 264,589 ONCOTHYREON INC COM 682324108 2,374 728,103 SH SOLE 0 0 728,103 PFIZER INC COM 717081103 5,618 320,851 SH SOLE 0 0 320,851 ARDEA BIOSCIENCES INC COM 03969P107 6,010 231,144 SH SOLE 0 0 231,144 RAPTOR PHARMACEUTICAL CORP COM 75382F106 5,100 1,401,223 SH SOLE 0 0 1,401,223 SHANGPHARMA CORP SPONSORED ADR 81943P104 1,108 96,336 SH SOLE 0 0 96,336 TRIUS THERAPEUTICS INC COM 89685K100 1,189 320,488 SH SOLE 0 0 320,488 UROPLASTY INC COM NEW 917277204 2,625 651,349 SH SOLE 0 0 651,349 WORLD HEART CORP COM NO PAR 980905400 1,795 798,006 SH SOLE 0 0 798,006 WELLPOINT INC COM 94973V107 3,350 58,915 SH SOLE 0 0 58,915 YM BIOSCIENCES INC COM 984238105 1,795 770,338 SH SOLE 0 0 770,338 INTERMUNE INC CALL 45884X903 3,136 1,782 CALL SOLE 0 0 -
-----END PRIVACY-ENHANCED MESSAGE-----